跳轉至內容
Merck
全部照片(2)

文件

89287

Supelco

霉酚酸

analytical standard

同義詞:

6-(1,3-二氢-7-羟基-5-甲氧基-4-甲基-1-氧代异苯并呋喃-6-基)-4-甲基-4-己酸, 6-(4-羟基-6-甲氧基-7-甲基-3-氧代-5-酞酰)-4-甲基-4-己烯酸, NSC 129185

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C17H20O6
CAS號碼:
分子量::
320.34
Beilstein:
1295848
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

analytical standard

品質等級

化驗

≥98.5% (HPLC)

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable

雜質

≤1.0% water

應用

forensics and toxicology
pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

SMILES 字串

COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O

InChI

1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+

InChI 密鑰

HPNSFSBZBAHARI-RUDMXATFSA-N

基因資訊

尋找類似的產品? 前往 產品比較指南

一般說明

霉酚酸是酯前药霉酚酸酯(MPM)的一种活性代谢产物,其可用作免疫抑制剂以防止器官移植排斥并用于某些自身免疫性疾病的治疗。

應用

产自短密青霉的霉酚酸(MPA)是肌苷单磷酸脱氢酶的一种选择性抑制剂,从而能够抑制T和B淋巴细胞中的DNA合成。 它还可作为免疫抑制剂,并在人淋巴和单核细胞系中作为单核细胞分化和诱导的诱导剂。 MPA作为一种选择剂可用于经转染而表达了大肠杆菌黄嘌呤-鸟嘌呤磷酸核糖基转移酶基因的动物细胞,其推荐用量为25μg/mL。
有关合适仪器技术的更多信息,请参考产品分析证书。如需进一步支持,请联系技术服务。
霉酚酸可作为参考标准品,通过超高效液相色谱联用串联质谱对人体血浆中的分析物进行测定。

生化/生理作用

作用方式:本品通过抑制细胞因子诱导的一氧化氮生成,抑制嘌呤核苷酸的早期生物合成,并作为 IMP 脱氢酶的特异性抑制剂发挥作用。

注意

供应后,本品应在 2-8°C 干燥条件下储存,适当储存时可保持稳定 5 年。

準備報告

麦考酚酸可溶于 50 mg/mL 甲醇,产生无色至淡黄色溶液,以及氯仿、二氯甲烷、乙醇和 1 N 氢氧化钠溶液。复溶后,建议通过 0.22 μm 过滤器灭菌m 孔径过滤器,分装,-20°C 冷冻。

訊號詞

Danger

危險分類

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Muta. 2 - Repr. 1B - STOT RE 1 Oral

標靶器官

Immune system

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

LC- MS/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum.
Merrigan SD, et al.
Clinical mass spectrometry, 3, 41- 48 (2017)
Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry.
Upadhyay V, et al.
Journal of Pharmaceutical Analysis, 4(3), 205- 216 (2014)
Hylke de Jonge et al.
Therapeutic drug monitoring, 31(4), 416-435 (2009-06-19)
Although therapeutic drug monitoring (TDM) of immunosuppressive drugs has been an integral part of routine clinical practice in solid organ transplantation for many years, ongoing research in the field of immunosuppressive drug metabolism, pharmacokinetics, pharmacogenetics, pharmacodynamics, and clinical TDM keeps
Neal M Davies et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22(9), 2440-2448 (2007-06-15)
Patient and graft survival following renal transplantation have improved markedly over the past decade, meaning that physician attention has turned more towards minimizing short- and long-term toxicities associated with immunosuppressive regimens. Gastrointestinal (GI) adverse events are common following renal transplantation
Burkhard Tönshoff et al.
Transplantation reviews (Orlando, Fla.), 25(2), 78-89 (2011-04-02)
Mycophenolate mofetil (MMF) is widely used for maintenance immunosuppressive therapy in pediatric renal and heart transplant recipients. Children undergo developmental changes (ontogeny) of drug disposition, which may affect drug metabolism of the active compound mycophenolic acid (MPA). Therefore, a detailed

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務